Ronai ZA - Search Results

1

Melanoma models for the next generation of therapies.

Patton EE, Mueller KL, Adams DJ, Anandasabapathy N, Aplin AE, Bertolotto C, Bosenberg M, Ceol CJ, Burd CE, Chi P, Herlyn M, Holmen SL, Karreth FA, Kaufman CK, Khan S, Kobold S, Leucci E, Levy C, Lombard DB, Lund AW, Marie KL, Marine JC, Marais R, McMahon M, Robles-Espinoza CD, Ronai ZA, Samuels Y, Soengas MS, Villanueva J, Weeraratna AT, White RM, Yeh I, Zhu J, Zon LI, Hurlbert MS, Merlino G. Patton EE, et al. Among authors: ronai za. Cancer Cell. 2021 May 10;39(5):610-631. doi: 10.1016/j.ccell.2021.01.011. Epub 2021 Feb 4. Cancer Cell. 2021. PMID: 33545064 Free PMC article. Review.

2

ATF2 confers radiation resistance to human melanoma cells.

Ronai Z, Yang YM, Fuchs SY, Adler V, Sardana M, Herlyn M. Ronai Z, et al. Oncogene. 1998 Jan 29;16(4):523-31. doi: 10.1038/sj.onc.1201566. Oncogene. 1998. PMID: 9484842

3

Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells.

Krasilnikov M, Adler V, Fuchs SY, Dong Z, Haimovitz-Friedman A, Herlyn M, Ronai Z. Krasilnikov M, et al. Mol Carcinog. 1999 Jan;24(1):64-9. doi: 10.1002/(sici)1098-2744(199901)24:1<64::aid-mc9>3.0.co;2-2. Mol Carcinog. 1999. PMID: 10029412

4

Melanoma biology and progression.

Herlyn M, Ferrone S, Ronai Z, Finerty J, Pelroy R, Mohla S. Herlyn M, et al. Cancer Res. 2001 Jun 1;61(11):4642-3. Cancer Res. 2001. PMID: 11389102 No abstract available.

5

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z, Aaronson SA. Dong J, et al. Cancer Res. 2003 Jul 15;63(14):3883-5. Cancer Res. 2003. PMID: 12873977

6

Rewired ERK-JNK signaling pathways in melanoma.

Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. Lopez-Bergami P, et al. Cancer Cell. 2007 May;11(5):447-60. doi: 10.1016/j.ccr.2007.03.009. Cancer Cell. 2007. PMID: 17482134 Free PMC article.

7

Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.

Abbas S, Bhoumik A, Dahl R, Vasile S, Krajewski S, Cosford ND, Ronai ZA. Abbas S, et al. Among authors: ronai za. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6769-78. doi: 10.1158/1078-0432.CCR-07-1536. Clin Cancer Res. 2007. PMID: 18006779 Free PMC article.

8

Roadmap for new opportunities in melanoma research.

Herlyn M, Halaban R, Ronai Z, Schuchter L, Berwick M, Pinkel D. Herlyn M, et al. Semin Oncol. 2007 Dec;34(6):566-76. doi: 10.1053/j.seminoncol.2007.09.004. Semin Oncol. 2007. PMID: 18083380

9

BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma.

Gaitonde S, De SK, Tcherpakov M, Dewing A, Yuan H, Riel-Mehan M, Krajewski S, Robertson G, Pellecchia M, Ronai Z. Gaitonde S, et al. Pigment Cell Melanoma Res. 2009 Apr;22(2):187-95. doi: 10.1111/j.1755-148X.2009.00544.x. Epub 2009 Jan 17. Pigment Cell Melanoma Res. 2009. PMID: 19175524 Free PMC article.

10

Tricking melanoma to self-digest: a deal of a meal!

Kim H, Ronai Z. Kim H, et al. Cancer Cell. 2009 Aug 4;16(2):83-4. doi: 10.1016/j.ccr.2009.07.006. Cancer Cell. 2009. PMID: 19647216 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

321 results

Search Page